Self-administered Intravaginal 2% Lidocaine Gel Prior to Intrauterine Device Insertion in Nulliparous Women
Status:
Completed
Trial end date:
2013-05-01
Target enrollment:
Participant gender:
Summary
This study is designed to evaluate if self-inserted intravaginal 2% lidocaine gel is
effective at decreasing pain during intrauterine device insertion in nulliparous women.